Pages that link to "Q24658338"
Jump to navigation
Jump to search
The following pages link to Looking for the role of cannabinoid receptor heteromers in striatal function (Q24658338):
Displaying 37 items.
- Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics (Q24630645) (← links)
- Adenosine-cannabinoid receptor interactions. Implications for striatal function (Q28286488) (← links)
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ (Q28298445) (← links)
- A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation (Q28728678) (← links)
- G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. (Q30385233) (← links)
- Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats (Q30475004) (← links)
- Cue-conditioned alcohol seeking in rats following abstinence: involvement of metabotropic glutamate 5 receptors (Q33685890) (← links)
- A putative 'pre-nervous' endocannabinoid system in early echinoderm development (Q33837421) (← links)
- Habit formation: implications for alcoholism research (Q33897637) (← links)
- Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity (Q34002281) (← links)
- Dissociation of genetic and hormonal influences on sex differences in alcoholism-related behaviors (Q34064001) (← links)
- Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers (Q34094605) (← links)
- Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. (Q34345068) (← links)
- Pathophysiological roles for purines: adenosine, caffeine and urate (Q35008049) (← links)
- Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist (Q35046370) (← links)
- Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation (Q35227731) (← links)
- Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. (Q35489240) (← links)
- Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection (Q35499568) (← links)
- Local Control of Extracellular Dopamine Levels in the Medial Nucleus Accumbens by a Glutamatergic Projection from the Infralimbic Cortex (Q36480264) (← links)
- The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing (Q36630516) (← links)
- Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission (Q36924618) (← links)
- Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. (Q37734568) (← links)
- Label-free screening assays: a strategy for finding better drug candidates (Q37856304) (← links)
- Reward, interrupted: Inhibitory control and its relevance to addictions (Q38113046) (← links)
- Cannabis, a complex plant: different compounds and different effects on individuals (Q38132167) (← links)
- Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (Q38522769) (← links)
- Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis (Q38604909) (← links)
- Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure (Q38636791) (← links)
- Cannabinoid receptors CB1 and CB2 form functional heteromers in brain (Q39359086) (← links)
- Cannabinoids in Parkinson's Disease (Q42258332) (← links)
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose (Q42320778) (← links)
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment (Q43299005) (← links)
- Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice (Q44348793) (← links)
- The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease (Q60715991) (← links)
- Endocannabinoid-Enhanced "Liking" in Nucleus Accumbens Shell Hedonic Hotspot Requires Endogenous Opioid Signals. (Q64901939) (← links)
- Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system (Q82237362) (← links)
- Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome (Q90480148) (← links)